Enfusion

Enfusion EBITDA per Employee

Delisted

The EBITDA per Employee of Enfusion (ENFN) as of Nov 7, 2026 is 5,384.95 USD. In the previous year, EBITDA per Employee was 10,453.19 USD — a change of -48.49% (lower).

EBITDA per Employee

5,384.95USD

YoY

-48.49%

Last updated:

EBITDA per Employee of Enfusion is 2024 5,384.95 USD. EBITDA per Employee of Enfusion was 2023 10,453.19 USD. It decreases by -48.49% lower compared to the previous year.

The Enfusion EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
12,133.86 USD
Jan 1, 2020
5,314.09 USD
Jan 1, 2021
-242,405.07 USD
Jan 1, 2022
-10,467.19 USD
Jan 1, 2023
10,453.19 USD
Jan 1, 2024
5,384.95 USD
The Enfusion EBITDA per Employee history
YEAREBITDA per EmployeeYoY
5,384.95USD-48.49%
10,453.19USD-199.87%
-10,467.19USD-95.68%
-242,405.07USD-4,661.56%
5,314.09USD-56.20%
12,133.86USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

EBITDA per Employee of Enfusion is 5,384.95 USD in 2024.

EBITDA per Employee of Enfusion changed from 10,453.19 USD to 5,384.95 USD, representing a -48.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Enfusion since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Enfusion

All Key Metrics — Enfusion